The data, which was analyzed by healthcare research firm 3 Axis Advisors, indicated prices are expected to increase about 5% in January, according to Antonio Ciaccia, president of the firm, told the news outlet. He said a 5% jump in price each year is typical to keep pace with inflation.
The drugmakers attribute the bump to inflation and ongoing supply chain issues, according to the report.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
